Megaloblastic Anemia Testing
Click here for topics associated with this algorithm
INDICATIONS FOR TESTING
Patient presents with megaloblastic anemia and/or neurologic symptoms
ORDER
Vitamin B12
Folate (for patient with known risk factors)
Vitamin B12 >400 pg/mL Vitamin B12 100-400 pg/mL Low folate levels only Low or normal folate
Vitamin B12
levels and high suspicion
<100 pg/mL
for deficiency
Folate deficiency Low
ORDER
Occasionally, clinician may Methylmalonic Acid, Serum
find normal levels of B12 in ORDER
or Plasma (Vitamin B12
symptomatic patients (usually Folate, RBC
Status)
neurologic symptoms) No
B12 deficiency Normal
folate deficiency
MMA and homocysteine may
be appropriate to confirm B12 <0.4 mol/L >0.4 mol/L
deficiency, as homocysteine
may have a role in detecting
folate or B12 deficiency Not
pernicious
anemia
ORDER Optional antibody testing when MMA >0.4 mol/L
Methylmalonic Acid, Serum or
(MMA >0.4 mol/L confirms B12 deficiency )
Plasma (Vitamin B12 Status)
Homocysteine, Total
ORDER
Intrinsic Factor Blocking Antibody
Both elevated
Positive Negative
Pernicious ORDER
Confirmed B12 anemia Gastric Parietal Cell
deficiency Antibody, IgG
Positive Negative
Pernicious ORDER
anemia Gastrin
<100 pg/mL >100 pg/mL
Not pernicious Pernicious anemia
anemia (indirect confirmation)
2006 ARUP Laboratories. All Rights Reserved. Revised 02/09/2015 www.arupconsult.com